452 related articles for article (PubMed ID: 35400056)
1. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran.
Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R
Front Public Health; 2022; 10():832003. PubMed ID: 35400056
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study.
Poustchi H; Darvishian M; Mohammadi Z; Shayanrad A; Delavari A; Bahadorimonfared A; Eslami S; Javanmard SH; Shakiba E; Somi MH; Emami A; Saki N; Hormati A; Ansari-Moghaddam A; Saeedi M; Ghasemi-Kebria F; Mohebbi I; Mansour-Ghanaei F; Karami M; Sharifi H; Pourfarzi F; Veisi N; Ghadimi R; Eghtesad S; Niavarani A; Ali Asgari A; Sadeghi A; Sorouri M; Anushiravani A; Amani M; Kaveh S; Feizesani A; Tabarsi P; Keyvani H; Markarian M; Shafighian F; Sima A; Sadjadi A; Radmard AR; Mokdad AH; Sharafkhah M; Malekzadeh R
Lancet Infect Dis; 2021 Apr; 21(4):473-481. PubMed ID: 33338441
[TBL] [Abstract][Full Text] [Related]
3. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study.
Ocias LF; Skogstam A; Kjerstadius T; Lundin F; Tevell S
Infect Dis (Lond); 2021; 53(12):920-929. PubMed ID: 34350813
[TBL] [Abstract][Full Text] [Related]
4. A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.
Wattal C; Oberoi JK; Goel N; Datta S; Raveendran R; Rao BK; Kumar R
Indian J Med Microbiol; 2021; 39(4):528-533. PubMed ID: 34688485
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of SARS-CoV-2 antibodies among healthcare workers in Dutch hospitals after the 2020 first wave: a multicentre cross-sectional study with prospective follow-up.
Recanatini C; GeurtsvanKessel CH; Pas SD; Broens EM; Maas M; van Mansfeld R; Mutsaers-van Oudheusden AJG; van Rijen M; Schippers EF; Stegeman A; Tami A; Veldkamp KE; Visser H; Voss A; Wegdam-Blans MCA; Wertheim HFL; Wever PC; Koopmans MPG; Kluytmans JAJW; Kluytmans-van den Bergh MFQ;
Antimicrob Resist Infect Control; 2023 Nov; 12(1):137. PubMed ID: 38031155
[TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers & implications of infection control practice in India.
Gupta R; Dwivedi T; Gajendra S; Sahoo B; Gupta SK; Vikas H; Singh AR; Mohan A; Bhatnagar S; Singh S; Wundavalli L; Guleria R
Indian J Med Res; 2021 Jan & Feb; 153(1 & 2):207-213. PubMed ID: 33642348
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.
Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M
Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children's Hospital.
Tariverdi M; Mohammadi H; Hassanzadeh F; Tamaddondar M
BMC Infect Dis; 2024 Feb; 24(1):253. PubMed ID: 38395759
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence, infection, and personal protective equipment use among Colombian healthcare workers during the COVID-19 pandemic.
Beltrán EO; Martignon S; Coronel-Ruiz C; Velandia-Romero ML; Romero-Sanchez C; Avila V; Castellanos JE
Front Public Health; 2023; 11():1225037. PubMed ID: 37900032
[TBL] [Abstract][Full Text] [Related]
10. Seroprevalence in health care workers during the later phase of the second wave: Results of three hospitals in Serbia, prior to vaccine administration.
Markovic-Denic L; Zdravkovic M; Ercegovac M; Djukic V; Nikolic V; Cujic D; Micic D; Pekmezovic T;
J Infect Public Health; 2022 Jul; 15(7):739-745. PubMed ID: 35691217
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence and longevity of SARS-CoV-2 nucleocapsid antigen-IgG among health care workers in a large COVID-19 public hospital in Saudi Arabia: A prospective cohort study.
Alasmari F; Mukahal M; Alqurashi AA; Huq M; Alabdrabalnabi F; AlJurayyan A; Alkahtani SM; Assari FS; Bashaweeh R; Salam R; Aldera S; Alkinani OM; Almutairi T; AlEnizi K; Tleyjeh I
PLoS One; 2022; 17(8):e0272818. PubMed ID: 35960736
[TBL] [Abstract][Full Text] [Related]
12. The Seroprevalence of SARS-CoV-2 Antibodies among HealthCare Workers in University Hospital in Krakow before the Era of Vaccination.
Żółtowska B; Barańska I; Jachowicz E; Sydor W; Maziarz B; Mydel K; Różańska A; Wizner B; Rosiński J; Kossowska M; Głomb K; Wójkowska-Mach J
Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409727
[TBL] [Abstract][Full Text] [Related]
13. The high level of adherence to personal protective equipment in health care workers efficiently protects them from COVID-19 infection.
Zangoue M; Safari H; Royce SG; Zangooie A; Rezapour H; Zangouei A; Fereidouni M
Work; 2021; 69(4):1191-1196. PubMed ID: 34421000
[TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Health Care Workers.
Santosh CS; Tukaram DP; Maharudra K; Balkrishna A; Chinmay G; Aniket I; Kinge K; Nilam J
J Assoc Physicians India; 2021 Aug; 69(8):11-12. PubMed ID: 34472805
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study.
Zamani M; Poustchi H; Mohammadi Z; Dalvand S; Sharafkhah M; Motevalian SA; Eslami S; Emami A; Somi MH; Yazdani-Charati J; Saki N; Karami M; Najafi F; Mohebbi I; Veisi N; Hormati A; Pourfarzi F; Ghadimi R; Ansari-Moghaddam A; Sharifi H; Roshandel G; Mansour-Ghanaei F; Joukar F; Shayanrad A; Eghtesad S; Niavarani A; Delavari A; Kaveh S; Feizesani A; Markarian M; Shafighian F; Sadjadi A; Darvishian M; Malekzadeh R
BMC Public Health; 2022 May; 22(1):1031. PubMed ID: 35606743
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy.
Poletti P; Tirani M; Cereda D; Guzzetta G; Trentini F; Marziano V; Toso C; Piatti A; Piccarreta R; Melegaro A; Andreassi A; Gramegna M; Ajelli M; Merler S
JAMA Netw Open; 2021 Jul; 4(7):e2115699. PubMed ID: 34228126
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers.
Allen N; Riain UN; Conlon N; Ferenczi A; Carrion Martin AI; Domegan L; Walsh C; Doherty L; O'Farrelly C; Higgins E; Kerr C; McGrath J; ; Fleming C; Bergin C
Epidemiol Infect; 2021 Apr; 149():e157. PubMed ID: 33902786
[TBL] [Abstract][Full Text] [Related]
18. Prospective surveillance study in a 1,400-bed university hospital: COVID-19 exposure at home was the main risk factor for SARS-CoV-2 point seroprevalence among hospital staff.
Bahrs C; Kimmig A; Weis S; Ankert J; Hagel S; Maschmann J; Stallmach A; Steiner A; Bauer M; Behringer W; Baier M; Kesselmeier M; Richert C; Zepf F; Walter M; Scherag A; Kiehntopf M; Löffler B; Pletz MW
Transbound Emerg Dis; 2022 Mar; 69(2):720-730. PubMed ID: 33605549
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
[TBL] [Abstract][Full Text] [Related]
20. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]